Sep 17, 2020

Reveal LINQ II™ Insertable Cardiac Monitor For Irregular Heartbeats

Information about the Reveal LINQ II ICM – a miniaturized implantable cardiac monitor designed to help physicians quickly and accurately diagnose irregular heartbeats.

The following media kits are made available to provide reporters with background information on the range of Medtronic therapies and the conditions they treat.

	Jul 7, 2020 Medtronic Gains FDA Clearance, CE Mark for LINQ II™ Insertable Cardiac Monitor (ICM) Next Generation ICM Offers Remote Programming with Improved Longevity and Enhanced Accuracy DUBLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) clearance and...
	Feb 21, 2018 NICE Issues Medtech Innovation Briefing Recognizing Medtronic Reveal LINQ in the Detection of Atrial Fibrillation After Stroke of Unknown Cause DUBLIN - February 21, 2018 - Today, the United Kingdom's National Institute for Health and Care Excellence (NICE) issued a Medtech Innovation Briefing on the use of the Medtronic Reveal LINQ(TM)...
	May 12, 2017 New Study Shows Medtronic Insertable Cardiac Monitors Detect High Rate of Atrial Fibrillation in Previously Undiagnosed High-Risk Patients Results from the REVEAL AF Study Show That AF Would Have Gone Undetected in the Majority of Patients at High-Risk for AF and Stroke If Cardiac Monitoring Was Limited to 30 Days DUBLIN and CHICAGO - May 12, 2017 - Medtronic plc (NYSE: MDT) today announced results from a new clinical study showing Medtronic Insertable Cardiac Monitors (ICM) detected a high incidence of...
	Mar 13, 2017 Medtronic Receives FDA Clearance for Reveal LINQ(TM) Insertable Cardiac Monitor (ICM) with TruRhythm(TM) Detection Device Delivers Improved Accuracy and Streamlined Data for Clinicians DUBLIN - Mar. 13, 2017 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its Reveal LINQ(TM) Insertable Cardiac Monitor (ICM) with...
	Sep 14, 2016 Medtronic Announces Approval and Launch of Reveal LINQ(TM) Insertable Cardiac Monitor in Japan Miniaturized Device Now Available for Use in Patients with Unexplained Syncope and Stroke DUBLIN - Sept. 14, 2016 - Medtronic plc (NYSE: MDT) today announced it has received Ministry of Health, Labor and Welfare (MHLW) approval of the Reveal LINQ Insertable Cardiac Monitor (ICM) System...
	Apr 20, 2016 Real-World Study Shows 72 Percent of Atrial Fibrillation Would Have Gone Undiagnosed in Stroke Patients if Cardiac Monitoring Had Been Limited to 30 Days Findings Demonstrate Detection of Atrial Fibrillation in Cryptogenic Stroke Patients with Medtronic Insertable Cardiac Monitor DUBLIN and VANCOUVER - APRIL 20, 2016 - Medtronic plc (NSYE: MDT) today announced one-year results from a real-world study of patients who had a cryptogenic stroke, or stroke of unknown cause. The...
	Feb 19, 2014 Medtronic Announces Global Launch of Miniature Cardiac Monitor, Reveal LINQ(TM) ICM Small, Wireless Monitor Provides Long-Term Remote Monitoring to Help Physicians Diagnose and Monitor Irregular Heartbeats MINNEAPOLIS - February 19, 2014 -Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance, CE (Conformité Européenne) Mark, and the global launch of...
	May 7, 2015 Medtronic Initiates Study Of ‘In-Office’ Insertion Of Reveal LINQ™ Cardiac Monitor RIO 2 Study Evaluates Safety and Effectiveness of Moving the Insertion Procedure from Hospital to Office Setting DUBLIN – May 7, 2015 – Medtronic plc (NYSE: MDT) today announced the first inoffice implant of its miniaturized cardiac monitor as part of the Medtronic Reveal LINQ In-Office 2 (RIO 2) Study....
	Feb 11, 2015 Medtronic Insertable Cardiac Monitors Detect Atrial Fibrillation In Stroke Patients In ‘Real – World’ Study Findings Reinforce Patient Benefit of Reveal LINQ in Real-World Setting DUBLIN and NASHVILLE – Feb. 11, 2015 – Medtronic plc (NYSE: MDT), today announced the results of a new “real-world” study of patients who have had a cryptogenic stroke (stroke of unknown...